Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
- Market proximity of Strides Pharma International AG, based in Zug, Switzerland, opens the way for rapid technology transfer and innovation within the European market
- Oren Weininger, longstanding leader at Fairmed Healthcare, heads the business as CEO and Chairman of the Board

Zug, Switzerland. Strides Pharma Science Limited, globally recognized as a leading pharmaceutical company operating across 100 countries and headquartered in Bangalore, India, is consolidating its European business through Strides Pharma International AG, based in Zug, Switzerland.
Strides Pharma specializes in the development and manufacturing of IP-led niche finished dosage formulations. With over three decades of research and development expertise, Strides Pharma continuously develops and delivers products with innovative and improved technologies at competitive prices. Notably, Strides Pharma is among the world's largest manufacturers of Ibuprofen and Macrogol in various forms. Their unique range of drug delivery technologies opens up versatile and lucrative opportunities within the ever-evolving target markets.
The partner-centric in-licensing portfolio of over 250 formulations is consolidated in synergICE as a one-stop shop. It includes generics, sterile injectables and value-added products, Women´s Health hormones, lyophilized orally dissolving tablets and end-to-end biopharmaceutical CDMO services.
Oren Weininger, newly appointed Chairman of the Board, stated, “With this strengthened European B2B presence, we can respond faster to our customers’ needs and provide flexible, innovative solutions, and interesting generic portfolio, including comprehensive support in supply chain & quality management and regulatory processes by Strides Pharma International and the EU GMP-site in Hamburg, Germany.”
Key Markets are Central and Southern Europe (especially Germany), Scandinavia, Benelux and the Visegrád countries.
For further information, please visit: www.fair-med.com/newsroom
Contact Agency What About Now, Andreas Schöpf
as@whataboutnow.de Tel. +49 160 90723690
Following his roles at Dexcel Pharma and Kamedis, Oren Weininger took the position of CEO at Fairmed Healthcare AG in 2014 and subsequently became owner in 2018. Strides Pharma, after a period of successful partnership, invested in the company in 2019, further bolstering leading Fairmed Healthcare product lines. In addition to being appointed Chairman of the Board of Strides Pharma International AG, Weininger continues to lead Fairmed Healthcare GmbH in Hamburg.
Strides Pharma Science Limited, headquartered in Bangalore, India, was incorporated in 1990. The company has a global manufacturing footprint with eight facilities spread across four continents and a strong presence in 100 countries. Strides Pharma is a key active pharmaceutical ingredient manufacturer and producer of various products; every fourth Ibuprofen tablet on the global market today is supplied by Strides Pharma.
Images

Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
EOPA Best Business Product of the Year 2025 - DYMO LetraTag 200B (Source:OPI)25.4.2025 08:00:04 CEST | Press release
DYMO® LETRATAG 200B WINS PRESTIGIOUS “BUSINESS PRODUCT OF THE YEAR” AWARD - REINFORCING RISE OF SMART ORGANIZATION
Democracy News Alliance: Canada must reduce reliance on extractive industries and U.S. exports, report finds22.4.2025 09:18:09 CEST | Press release
Los Angeles/Ottawa (DNA) - From dissatisfaction with the Trudeau government to dissatisfaction with Trump’s policies — compounded by general anxiety around tariffs, the economy and a deteriorating relationship with the U.S. — navigating an economic downturn should be an immediate priority for Canada as it heads into a federal election, a new report recommends.
“Relaxing rocks”: Spectacular naming of Mein Schiff Relax with Robbie Williams11.4.2025 08:51:53 CEST | Press release
For the first time, guests of three ships in the fleet were able to experience the festive moment together The staging of the naming ceremony, a choir and many technical refinements such as lasers, video mapping and LED wristbands ensured “endless moments” International superstar and feel-good ambassador of Mein Schiff Relax Robbie Williams wows over 12,000 people with his concert Three ships and a naming ceremony: unique and unprecedented fleet get-together – Mein Schiff 5, Mein Schiff 7 and Mein Schiff Relax in the port of Málaga
Germany’s new Migration Museum: This is What it Will Look Like10.4.2025 11:30:00 CEST | Press release
Cologne is getting ready to welcome a new attraction in 2029: The Museum Selma will showcase Germany's past and present as a society shaped by immigration. The exhibition, based on 150,000 artifacts and testimonies witnessing to the history of migration in Germany, will have its home in a former industrial hall, promising visitors a unique free-flow experience. Behind this all is an organization started by migrants themselves. The museum is being developed with public funding of 44.26 million euro. ATELIER BRÜCKNER will take the lead on the project’s architectural and exhibition design, with a particular focus on sustainability.
Ny utmerkelse som TOP-reiseoperatør3.4.2025 15:30:24 CEST | Pressemelding
Fornyet sertifisering i tide til 15-årsjubileet for selskapet.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom